Allgemeine Informationen
  • Krankheitskategorie Neonatale Erkrankungen (BASEC)
  • Rekrutierungsstatus Unbekannt (BASEC/ICTRP)
  • Studienstandort
    Bern, Zürich
    (BASEC)
  • Studienverantwortliche Stephanie Brezina ngn.mit-pb-studie@usz.ch (BASEC)
  • Datenquelle(n) BASEC: Import vom 27.09.2024 ICTRP: N/A
  • Letzte Aktualisierung 27.09.2024 10:28
HumRes61017 | SNCTP000005204 | BASEC2022-01519

Movement Imitation Therapy for Preterm Babies (MIT-PB): What influence does this early intervention have on the neuromotor development of preterm children with atypical spontaneous motor activity (General Movements)?

  • Krankheitskategorie Neonatale Erkrankungen (BASEC)
  • Rekrutierungsstatus Unbekannt (BASEC/ICTRP)
  • Studienstandort
    Bern, Zürich
    (BASEC)
  • Studienverantwortliche Stephanie Brezina ngn.mit-pb-studie@usz.ch (BASEC)
  • Datenquelle(n) BASEC: Import vom 27.09.2024 ICTRP: N/A
  • Letzte Aktualisierung 27.09.2024 10:28

Zusammenfassung der Studie

The Movement Imitation Therapy for Preterm Babies (MIT-PB) by Dr. Marina Soloveichick is a new treatment method for preterm infants that has been little studied so far. This study aims to find out whether the new treatment method has a greater positive influence on neuromotor development than conventional physiotherapy. To investigate this, there will be a control group and an intervention group, each with approximately 40 children. The children included in the study from the neonatology department of Inselspital Bern form the control group. The children included in the study from the neonatology clinic of USZ in Zurich form the intervention group. The children in the control group will be treated with conventional physiotherapy. Apart from documenting the frequency and contents of the treatments, nothing will change in the treatment. The children in the intervention group will be treated with conventional physiotherapy and additionally with MIT-PB. The parents will be introduced to the treatment so that they can carry out most of the treatment independently. They will be accompanied and supported by trained physiotherapists both in the hospital and after discharge. The treatment will be carried out until the age of 52 weeks (corrected three months). All children will undergo a test at 40 weeks, corrected three months, and two years to assess the child's neuromotor development status. Parents will be asked to complete a short self-efficacy questionnaire (PMP S-E) at the beginning of the study and at the three-month check-up. The total duration of the study per child is approximately 26 months.

(BASEC)

Untersuchte Intervention

The children in the intervention group will be treated in addition to conventional physiotherapeutic treatment by the physiotherapist and/or by the parents with MIT-PB. The MIT-PB starts in neonatology and continues at home until the age of 52 weeks. Essential in this treatment method according to Dr. Marina Soloveichick is the manual redirection of atypical spontaneous movements towards as fluid and variable movements as possible. The child should be awake, content, and active during the treatment. The MIT-PB should be applied 5 times a day for 10 minutes.

(BASEC)

Untersuchte Krankheit(en)

The neuromotor development of preterm children (under 32 weeks of gestation) with a high risk of mild to severe neuromotor developmental impairment.

(BASEC)

Kriterien zur Teilnahme
Children born before 32 weeks of gestation (in the neonatology clinic at USZ or the neonatology department of Inselspital Bern) and showing atypical General Movements (spontaneous movements) at 33-34 weeks of gestation and/or having a brain hemorrhage grade 3 or higher. (BASEC)

Ausschlusskriterien
Comorbidities that could further restrict the motor behavior of preterm children (such as syndromic diseases, neuromuscular diseases, or diseases affecting the musculature and/or the skeletal system) (BASEC)

Studienstandort

Bern, Zürich

(BASEC)

nicht verfügbar

Sponsor

nicht verfügbar

Kontakt für weitere Auskünfte zur Studie

Kontaktperson Schweiz

Stephanie Brezina

+41 44 255 92 78

ngn.mit-pb-studie@usz.ch

(BASEC)

Wissenschaftliche Auskünfte

nicht verfügbar

Name der bewilligenden Ethikkommission (bei multizentrischen Studien nur die Leitkommission)

Ethikkommission Zürich

(BASEC)

Datum der Bewilligung durch die Ethikkommission

04.11.2022

(BASEC)


ICTRP Studien-ID
nicht verfügbar

Offizieller Titel (Genehmigt von der Ethikkommission)
nicht verfügbar

Wissenschaftlicher Titel
nicht verfügbar

Öffentlicher Titel
nicht verfügbar

Untersuchte Krankheit(en)
nicht verfügbar

Untersuchte Intervention
nicht verfügbar

Studientyp
nicht verfügbar

Studiendesign
nicht verfügbar

Ein-/Ausschlusskriterien
nicht verfügbar

nicht verfügbar

Primäre und sekundäre Endpunkte
nicht verfügbar

nicht verfügbar

Registrierungsdatum
nicht verfügbar

Einschluss des ersten Teilnehmers
nicht verfügbar

Sekundäre Sponsoren
nicht verfügbar

Weitere Kontakte
nicht verfügbar

Sekundäre IDs
nicht verfügbar

Angaben zur Verfügbarkeit von individuellen Teilnehmerdaten
nicht verfügbar

Weitere Informationen zur Studie
nicht verfügbar

Ergebnisse der Studie

Zusammenfassung der Ergebnisse

nicht verfügbar

Link zu den Ergebnissen im Primärregister

nicht verfügbar